3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Influenza Vaccine: new trials by email Literature Review of Influenza Vaccine trials Research Report on Influenza Vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Imiquimod and Influenza Vaccine for Immunocompromised Patients Intanza, Mutagrip, Aldara - Influenza Vaccine | Phase 2 | Completed | University of Lausanne Hospitals | 70 | 2016-11-01 | 2017-10-10 |
| Immunogenicity of H5N1 Vaccine Following H5N2 A(H5N1) inactivated influenza vaccine (IIV), A(H5N2) live attenuated influenza vaccine (LAIV) - Influenza Vaccine | Phase 2 | Completed | PATH | 43 | 2014-05-01 | 2019-02-18 |
| A Phase 2 Study to Evaluate Immune Responses of FluMist® TIV, Trivalent Inactivated Influenza Virus Vaccine, FluMist, Influenza Virus Vaccine Live - Influenza Vaccine | Phase 2 | Completed | MedImmune LLC | 101 | 2007-05-01 | 2021-10-06 |
Influenza, Human (3) · HIV Infections (1)
Infections (3) · Orthomyxoviridae Infections (3) · RNA Virus Infections (3) · Respiratory Tract Diseases (3) · Respiratory Tract Infections (3) · Virus Diseases (3) · Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Lentivirus Infections (1) · Retroviridae Infections (1) · Sexually Transmitted Diseases (1) · Sexually Transmitted Diseases, Viral (1)
FluMist (1) · Imiquimod (1) · mutagrip (1)
MedImmune LLC (1) · PATH (1) · University of Lausanne Hospitals (1)
Russia (1) · Switzerland (1) · United States (1)
Maria Allende, M.D. (1) · Oleg I Kiselev, Ph.D. (1) · Oriol Manuel, MD (1)
PMID 21288852, PMID 21377898, PMID 23042206
2016 (1)